NHMRC Clinical Trials Centre
Publications
Articles

Research > Publications > Articles
CTC journal articles and reports

2008 2007 2006 2005 2004 2003 2002 2001 2000 All years
2008
Agustin C, Grand M, Gebski V, Turner S. Radiation therapists' perspective on barriers to clinical trials research. Journal of Medical Imaging and Radiation Oncology 2008; 52(2): 178–182.
Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy. Circulation 2008; 117(2): 192–199. Published online 17 Dec 2007.
Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371(9607): 117–125.
Duric VM, Butow PN, Sharpe L, Heritier S, Boyle F, Beith J, Wilcken NR, Coates AS, Simes RJ, Stockler MR. Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Education and Counseling 2008; 72: 329–245. Published online 21 Apr 2008.
Dyer SM, Levison DB, Chen RY, Lord SJ , Blamey S.Systematic review of the impact of endoscopic ultrasound on the management of patients with esophageal cancer. International Journal Technology Assessment in Health Care 2008; 24(1): 25–35.
Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A; LIPID Study Investigators. Monitoring cholesterol levels: measurement error or true change? Annals of Internal Medicine 2008;148(9): 656–661.
Hayes AJ, Clarke PM, Glasziou PG, Simes RJ, Drury PL, Keech AC. Can self-rated health be used for risk prediction in patients with type 2 diabetes? Diabetes Care 2008; 31(4): 795–797.
Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren R, Dixon JM, Irwig L. Accuracy and surgical impact of MRI in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. Journal of Clinical Oncology 2008; 26(19): 3248–2358. Published online 12 May 2008.
Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, Spirtas R, Ursin G. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case–control study. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(7): 1723–1730.
Nowak AK, Cebon J, Hargreaves C, Dhillon H, Findlay M, Gebski V, Stockler MR. Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2008; 4: 55–67.
Shakespeare TP, Gebski V, Tang J, Lim K, Lu JJ, Xiaojian Zhang, Guoliang Jiang. Influence of the way results are presented on research interpretation and medical decision making: the PRIMER Collaboration randomized studies. Medical Decision Making 2008; 28(1): 127–137. Published online 14 Dec 2007.
Stewart RA, North FM, Sharples KJ, Simes RJ, Tonkin AM, White HD; for the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Investigators. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study. New Zealand Medical Journal 2008; 121(1269): 11–23.
Tai B, De Stavola B, de Gruttola V, Gebski V, Machin D. First-event or marginal estimation of cause-specific hazards analysing correlated multivariate failure-time data? Statistics in Medicine 2008; 27: 922–936. Published online 5 June 2007.
West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; for the LIPID Study Investigators.The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal 2008; 29: 923–931. Published online 22 Feb 2008.
Letters
Kearney PM, Keech A, Simes J, Collins R, Baigent C; on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Statins and diabetes — authors' reply. Lancet 2008; 371(9626): 1752.
Keech A, Mitchell P, Summanen P, Davis T, Simes R. Fenofibrate and diabetic retinopathy — authors' reply. Lancet 2008; 371(9614): 722.
Book chapter
Glasziou PP, Irwig L, Heritier S. Monitoring cholesterol-modifying interventions. In: Glasziou PP, Irwig L, Aronson JK, editors. Evidence-based medical monitoring: from principles to practice. Blackwell BMJ Books, 2008. Chapter 18.
2007
Ahern V, Boyages J, Gebski V, Moon D, Wilcken N. Selective mastectomy in the management of locally advanced breast cancer. International Journal of Radiation Oncology, Biology, Physics 2007; 68(4):1010-1017. Published online 29 March 2007.
Ahern V, Koh ES, Gebski V, Sathiyaseelan Y. Paediatric medulloblastoma: patterns of care and radiotherapy quality assurance in Australia. Australasian Radiology 2007; 51(5): 458-464.
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–1798. Published online 17 May 2007.
Askie L, Duley L, Henderson-Smart D, Stewart L, on behalf of the PARIS Collaboration. Antiplatelet agents for prevention of pre-eclampsia — authors' reply [letter]. Lancet 2007; 370(9600): 1685–1686.
Beslija S, Bonneterre J, Burstein H, Cocquyt V, Gnant M, Goodwin P, Heinemann V, Jassem J, Köstler WJ, Krainer M, Menard S, Petit T, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H. Second consensus on medical treatment of metastatic breast cancer. Annals of Oncology 2007; 18: 215-225. Published online 10 July 2006.
Copt S, Heritier S. Robust alternatives to the F-test in mixed linear models based on MM-estimates. Biometrics 2007; 63(4): 1045-1052. Published online 2 May 2007.
Duric V, Butow P, Sharpe L, Boyle F, Beith J, Wilcken N, Heritier S, Coates A, Simes J, Stockler M. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology 2007; 16: 48–59. Published online 19 Jul 2006.
Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Economics 2007; 16: 195–209. Published online 15 Sep 2006 [has erratum].
Edmond JJ, French JK, Aylward PE , Wong CK, Stewart RA, Williams BF, De Pasquale CG, O'Connell RL, Van den Berg K, Van de Werf FJ, Simes RJ, White HD. Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2. European Heart Journal 2007; 28(12):1418–1424. Published online 11 May 2007.
Ferguson T, Wilcken N, Vagg R, Ghersi D, Nowak AK. Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews 2007; (4): CD004421.
Findlay M, Storey D, Gebski V, Hargreaves C, Cullingford G, Boyer M, Trotter J, Archer S, Davidson A, Johnston P, Yuen J, Dhillon H, Della-Fiorentina S, Richardson G, Truskett P, Goldstein D; on behalf of the AGITG. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601. Australian and New Zealand Journal of Surgery 2007; 77(4): 247–252.
Gebski V, Burmeister B, Smithers MB, Foo K, Zalcberg J, Simes J. Meta-analysis of the survival benefits from preoperative chemoradiation therapy and chemotherapy in oesophageal carcinoma. Lancet Oncology, Published online 15 February 2007.
Gebski V, Byth K, Langlands A. Statistical rigour is essential to clinical prediction [letter]. ANZ Journal of Surgery 2007; 77(7): 597–598.
Griffiths A, Marinovich L, Barton MB, Lord SJ. Cost analysis of Gamma Knife stereotactic radiosurgery. International Journal Technology Assessment in Health Care 2007; 23(4): 488-494.
Grimison P, Stockler M. Quality of life and adjuvant systemic therapy for early-stage breast cancer. Expert Reviews of Anticancer Therapy 2007; 7(8): 1123–1134.
Hancock K, Clayton JM, Parker S, Walder S, Butow P, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall M. Discrepant perceptions about end-of-life communication: a systematic review. Journal of Pain and Symptom Management 2007; 34 (2): 190-200.
Hancock K, Clayton JM, Parker SM, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH. Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliative Medicine 2007; 21(6): 507-517.
Hiukka A, Leinonen E, Jauhiainen M, Sundvall J, Ehnholm C, Keech AC, Taskinen MR. Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia. Published online 26 July 2007.
Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ. Cetuximab for the treatment of colorectal cancer. New England Journal of Medicine 2007; 357(20): 2040-2048.
Keech AC, Pike R, Granger RE, Gebski VJ. Interpreting the results of a clinical trial. Medical Journal of Australia 2007; 186 (6): 318–319.
Lin C, Turner S, Mai T, Kneebone A, Gebski V. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients. Australasian Radiology 2007; 51(6): 578-583.
Lord SJ, Irwig L, Simes RJ. In response to Sonke GS. Verbeek AL. Kiemeney LA. A philosophical approach to diagnostic test evaluation [comment]. Annals of Internal Medicine 2007; 146(10): 757.
Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N. A systematic review of the effectiveness of magnetic resonance imaging as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. European Journal of Cancer 2007; 43: 1905–1917. Published online 1 Aug 2007.
Mark DB, Van de Werf FJ, Simes RJ, White HD, Wallentin LC, Califf RM, Armstrong PW; VIGOUR Group. Cardiovascular disease on a global scale: defining the path forward for research and practice. European Heart Journal 2007; 28(21): 2678-2684. Published online 16 Oct 2007.
Marschner IC, Simes RJ, Keech A. Biases in the identification of risk factor thresholds and J-curves. American Journal of Epidemiology 2007; 166: 824–831. Published online 21 July 2007.
Nordsmark M, Eriksen J, Gebski V, Alsner J, Horsman M, Overgaard J. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Radiotherapy and Oncology 2007; 83(3): 389–397. Published online 17 May 2007.
Parker S, Clayton J, Hancock K, Walder S, Butow P, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall M. A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style and timing of information. Journal of Pain and Symptom Management 2006; 34(1): 81-93. Published online 24 May 2007.
Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NRC, Wyld D, Abdi E, Glasgow A, Beale PJ, Jefford M, Dhillon H, Heritier S, Carter C, Hickie IB, Simes RJ; the ZEST Trial Group. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology 2007; 8: 603–612. Published online 4 June 2007.
Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; for the Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. Archives of Internal Medicine 2007; 167(13): 1353–1359.
Tinker AV, Gebski V, Fitzharris B, Buck M, Stuart-Harris R, Beale P, Goldrick A, Rischin D. Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG 02-01. Gynecologic Oncology 2007; 104(3): 647–653. Published online 30 Oct 2006.
Walleser S, Griffiths A, Lord SJ, Howard K, Solomon MJ, Gebski V . What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clinical Gastroenterology and Hepatology 2007; 5(12): 1439-1446.
Wilcken NR, Gebski VJ, Pike R, Keech AC. Putting results of a clinical trial into perspective. Medical Journal of Australia 2007; 186 (7): 368–370.
Wilcken NR, Gebski VJ, Keech AC, Pike R. Words, words, words [reply]. Medical Journal of Australia 2007; 187(4) 256.
 
Book
Keech A, Gebski V, Pike R. Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials. Sydney: Australasian Medical Publishing Company; 2007.
 
Collaborative groups
Kuebler JP, Colangelo L, O'Connell MJ, Smith RE, Yothers G, Begovic M, Robinson B, Seay TE, Wolmark N. Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis. Cancer 2007; 110(9): 1945–1950. [NSABP]
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 2007; 25(15): 1960–1966. Published online 23 Apr 2007. [AGITG]
Verweija J, Casalib PG, Kotasek D, Le Cesne A, Reichard P, Judson IR, Issels R, van Oosterom AT, Van Glabbeke M, Blay JY. Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analysis of EORTC- IS G-AGITG study 62005. European Journal of Cancer 2007; 43(6): 974–978. Published online 2 Mar 2007. [AGITG]
 
Report
Walleser S, Lord S. Nationally funded centres: paediatric liver transplantation. Canberra: Department of Health and Ageing; 2007.
2006
Askie L, Ghersi D, Simes J. Prospective registration of clinical trials. Australian Journal of Physiotherapy 2006; 52(4): 237–239.
Atlantis E, Barnes EH, Singh MA. Efficacy of exercise for treating overweight in children and adolescents: a systematic review. International Journal of Obesity 2006; 30(7): 1027–1040. Published online 14 Mar 2006.
Atlantis E, Chow CM, Kirby A, Fiatarone Singh MA. Worksite intervention effects on physical health: a randomized controlled trial. Health Promotion International 2006; 21(3): 191–200. Published online 4 Apr 2006.
Atlantis E, Chow CM, Kirby A, Fiatarone Singh MA. Worksite intervention effects on sleep quality: a randomized controlled trial. Journal of Occupational Health Psychology 2006; 11(4): 291–304.
Baigent C, Keech A, Kearney P, Collins R, Simes J; on behalf of the Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of cholesterol-lowering treatment—authors' reply [letter]. Lancet 2006; 367(9509): 470–471.
Burgess DC, Burgess MA, Leask J. The MMR vaccination and autism controversy in the United Kingdom 1997–2005: inevitable community outrage or a failure of risk communication? Vaccine 2006; 24: 3921–3928.
Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. European Heart Journal. 2006; 27: 2846–2857. Published online 2 Oct 2006.
Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, Harrington RA, White HD, Simes RJ, Califf RM, Topol EJ, Easton JD. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006; 37(6): 1427–1431. Published online 27 April 2006.
Byth K, Cox DR, Forder P. Assessing the relationship between symptoms of allergic rhinoconjunctivitis and pollen counts. Australian and New Zealand Journal of Statistics 2006; 48(4): 417–428.
Cebon J, Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators. Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer 2006; 95(7): 853–861. Published online 5 Sep 2006. [Hargreaves C, Stockler M, Nowak A, Dhillon H, Dickman B, Gebski V, writing committee.
Chan QW, Upshur R, Singh JA, Ghersi D, Chapuis F, Altman D. Waiving confidentiality for the greater good. BMJ 2006; 332: 1086–1089.
Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC; on behalf of the WH IS P (Women's Hormone Intervention Secondary Prevention Study) Pilot Study Investigators. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. European Heart Journal 2006. Published online 9 Aug 2006.
Crawford BAL, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, McCaughan GW. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 2006; 144: 239–248.
Duric V, Butow P, Sharpe L, Boyle F, Beith J, Wilcken N, Heritier S, Coates A, Simes J, Stockler M. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology. Published online 19 July 2006.
Dwyer MK, Gebski VJ, Jayamohan J. The bottom line: outcomes after conservation treatment in anal cancer. Australasian Radiology 2006; 50: 46–51.
Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Economics 2006. Published online 15 Sep 2006.
Edmond JJ, French JK, Stewart RAH, Aylward PA, De Pasquale CG, Williams BF, O'Connell RL, Simes RJ, White HD, for the HERO-2 Investigators. Frequency of recurrent ST elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques. American Journal of Cardiology 2006; 97(7): 947–951.
Galbraith S, Marschner IC, Simes J. Missing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies. Statistics in Medicine 2006: 25: 415–431.
Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. Journal of the National Cancer Institute 2006; 98: 26–38.
Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. Journal of the National Cancer Institute 2006; 98: 26–38.
Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D; European Organization for Research and Treatment of Cancer Quality-of-Life Group. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer 2006; 107(8): 1812–1822.
Grieve SM, Ansquer JC, Keech AC. Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and type 2 diabetes. Future Cardiology 2006; 2(6): 635–646.
Hancock K, Clayton J, Parker S, Walder S, Butow P, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall M. Discrepant perceptions about end-of-life communication: a systematic review. Journal of Pain and Symptom Management 2006. In press.
Review , Appendixes (large file)
Hauser CA, Stockler MR, Tattersall MH. Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Supportive Care in Cancer 2006; 14(10): 999–1011. Published online 18 May 2006.
Howard KH, Lord SJ, Speer A, Gibson RN, Padbury R, Kearney B. Value of magnetic resonance cholangeopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategies. International Journal of Technology Assessment in Health Care 2006; 22 (1): 109–118.
Janda M, Gebski V, Forder P, Jackson D, Williams G, Obermair A; for the LACE Trial Committee. Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial. Contemporary Clinical Trials 2006; 27: 353–363. Published online 4 May.
Jones D, Ghersi D, Wilcken N. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database of Systematic Reviews 2006; 3: CD003368.
Jones M, Onslow M, Packman A, Gebski V. Guidelines for statistical analysis of percentage of syllables stuttered data. Journal of Speech, Language, and Hearing Research 2006; 49(4): 867–878.
Keech A, Simes J, Barter P, Best J, Scott R, Taskinen MR; FIELD Management Committee. Correction to the FIELD study report [letter]. Lancet 2006; 368(9545): 1415.
Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, Stansby G. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. European Journal of Vascular and Endovascular Surgery 2007; 33(4): 442–450.
Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine 2006; 144(11): 850–855.
Matsuura Y, Robertson G, Marsden DE, Kim SN, Gebski V, Hacker NF. Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecologic Oncology 2006. Published online 29 Sep 2006.
Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Gebski V, West C, Lindegaard JC, Havsteen H, Davidson SE, Hunter R, Raleigh JA, Overgaard J. The prognostic value of pimonidazole and tumour pO(2) in human cervix carcinomas after radiation therapy: A prospective international multi-center study. Radiotherapy and Oncology 2006; 80(2): 123–131. Published online 3 Aug 2006.
Orlandini A, Diaz R, Wojdyla D, Pieper K, Van de Werf F, Granger CB, Harrington RA, Boersma E, Califf RM, Armstrong P, White H, Simes J, Paolasso E. Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes. European Heart Journal 2006; 27: 527–533.
Shakespeare TP, Gebski VJ, Thiagarajan A, Jay Lu J. Development of a spreadsheet for the calculation of new tools to improve the reporting of the results of medical research. Medical Informatics and the Internet in Medicine 2006; 31(2): 121–127.
Solomon MJ, Lord SJ, Walleser S. Review: computed tomographic colonography is accurate for medium and large colorectal polyps and cancer. Evidence Based Medicine 2006; 11: 153.

Steinbeck KS, Baur LA, Morris AM, Ghersi D. A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity. International Journal of Obesity 2006; 30: 2–5.

Stocker R, Pollicino C, Gay CA, Nestel P, Colquhoun D, Whiting M, Tonkin A, Sullivan D, Simes J. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. Atherosclerosis 2006; 187(1): 198–204. Published online 10 October 2005.
Stockler MR, Tattersall MHN, Boyer MJ, Clarke SJ, Beale PJ, Simes RJ. Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. British Journal of Cancer 2006; 94: 208–212.
Tinker AV, Gebski V, Fitzharris B, Buck M, Stuart-Harris R, Beale P, Goldrick A, Rischin D. Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG 02-01. Gynecologic Oncology 2006. Published online 30 Oct 2006.
Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J, on behalf of the LIPID Study Investigators. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American Heart Journal 2006; 151(6): 1305–1312.
Van Glabbeke M, Verweij J, Casali PG, Simes J, Cesne AL, Reichardt P, Issels R, Judson IR, van Oosterom AT, Blay JY. Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-IS G-AGITG). European Journal of Cancer 2006; 42(14) :2277–2285. Published online 26 July 2006.
Veness M, Foroudi F, Gebski V, Timms I, Sathiyaseelan Y, Cakir B, Tiver K. Use of topical misoprostol to reduce radiation-induced mucositis: Results of a randomized, double-blind, placebo-controlled trial. Australasian Radiology 2006; 50(5): 468–474.
Walleser S, Salkeld G, Donovan B. The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia. Sexual Health 2006; 3(4): 225–234
 
Reports
Dyer S, Griffiths A, Eckermann S, Lord S. Assisted reproductive technologies review. Sydney: NHMRC Clinical Trials Centre; 2006. Available at:
Dyer S, Griffiths A, Lord S, Lei W, Tai F, and the Medical Services Advisory Committee. Nationally funded centres: peritonectomy. Canberra: Department of Health and Ageing; 2006.
Higgins A, Eckermann S, Lord S, and the Medical Services Advisory Committee. UroVysion FISH assay. Canberra: Department of Health and Ageing; 2005. Available at
http://www.health.gov.au/internet/wcms/publishing.nsf/content/356F66F51D5D4163CA2571F50009EE7B/$File/artrc_appendices.pdf
Griffiths A, Lei W, Lord S, Parker S, Thongyoo S, Walleser S, and the Medical Services Advisory Committee. Breast magnetic resonance imaging. Canberra: Department of Health and Ageing; 2006.
Marinovich L, Griffiths A, Lei W, Walleser S, Lord S, and the Medical Services Advisory Committee. Nationally funded centres: selective dorsal rhizotomy. Canberra: Department of Health and Ageing; 2006.
Marinovich L, Griffiths A, Lord S, and the Medical Services Advisory Committee. Gamma Knife radiosurgery. Canberra: Department of Health and Ageing; 2006.
Parker S, Clayton J, Hancock K, Walder S, Butow P, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall M. Communicating prognosis and issues surrounding end of life in adults in the advanced stages of a life-limiting illness: a systematic review. Sydney: NHMRC Clinical Trials Centre and the University of Sydney; 2006.
Review , Appendixes (large file)
Walleser S, Dyer S, Griffiths A, Lord S, Lei W, and the Medical Services Advisory Committee. Nationally funded centres: pulmonary thromboendarterectomy. Canberra : Department of Health and Ageing; 2006.
Walleser S, Lord S, Griffiths A, Howard K, Higgins A; for the Medical Services Advisory Committee. Computed tomography colonography. Canberra: Department of Health and Ageing; 2005.
 
Collaborative groups
Alexander KP, Newby LK, Bhapkar MV, White HD, Hochman JS, Pfisterer ME, Moliterno DJ, Peterson ED, Van de Werf F, Armstrong PW, Califf RM; for the SYMPHONY and 2nd SYMPHONY investigators. International variation in invasive care of the elderly with acute coronary syndromes. European Heart Journal 2006; 27(13): 1558–1564. Published online 7 June 2006 . [RJ Simes, AC Keech, SYMPHONY steering committee]
Boersma E and the Primary Coronary Angioplasty vs. Thrombolysis (PCAT) Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. European Heart Journal 2006; 27(7): 779–788. Published online 2 Mar 2006. [RJ Simes, study co-chair]
Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S, Stul M, Casali PG, Zalcberg J, Verweij J, Van Glabbeke M, Hagemeijer A, Judson I; On behalf of the EORTC Soft Tissue and Bone Sarcoma Group, The Italian Sarcoma Group and the Australasian Gastro-Intestinal Trials Group. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. European Journal of Cancer 2006; 42(8): 1093–103. Published online 16 April.
Wong CK, Gao W, Raffel OC, French JK, Stewart RA, White HD; HERO-2 Investigators. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet 2006; 367(9528): 2061–2067. [*Simes J, steering committee and executive]
Wong CK, Stewart RA, Gao W, French JK, Raffel C, White HD, for the Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators*. Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. European Heart Journal 2006: 27(1): 21–28. [*Simes J, steering committee and executive]
2005

Ackland SP, Jones M, Tu D, Simes J, Yuen J, Sargeant A-M, Dhillon H, Goldberg RM, Abdi E, Shepherd L, Moore MJ. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. British Journal of Cancer 2005; 93: 1235–1243.
Briffa T, Keech A, Harris P, Heath R, Freedman B, Donaldson L, Briffa K. Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial. Medical Journal of Australia 2005; 183: 450–455.
Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW, for the Trans-Tasman Radiation Oncology Group (TROG) and the Australasian Gastro-Intestinal Trials Group (AGITG) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncology 2005; 6(9): 659–668.    
Byth K, Cox DR. On the relation between initial value and slope. Biostatistics 2005; 6(3): 395–403.
Carrick S, Parker S, Wilcken N, Ghersi D, Marzo M, Simes J. Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews 2005; (2): CD003374.

Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–1278. [Keech A, Pollicino C, Kirby A, Sourjina T, Simes J, members of writing committee]

Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR. Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? British Journal of Cancer 2005; 93: 1319–1323.
Duric VM, Stockler MR, Heritier S, Boyle F, Beith J, Sullivan A, Wilcken N, Coates AS, Simes RJ. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Annals of Oncology 2005; 16(11): 1786–1794.

FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events among 9795 people with type 2 diabetes mellitus (the FIELD study): a randomised controlled trial. Lancet 2005: 366 (9500): 1849–1861. [Keech A, study chair and principal investigator, executive and writing committees; Simes J, executive and writing committees; Forder P, Pillai A, writing committee]

FIELD Study Investigators. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, a randomized, placebo-controlled trial: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]. Cardiovascular Diabetology 2005; 4(1): 13. [Keech A, study chair and principal investigator, executive and writing committees; Simes J, executive and writing committees; Forder P, writing committee]

Foo K, Gebski V, Yeghiaian-Alvandi R, Foroudi F, Cakir B. Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer. Australasian Radiology 2005; 49(2): 108–112.
Forder PM, Gebski VJ, Keech AC. Allocation concealment and blinding: when ignorance is bliss. Medical Journal of Australia 2005; 182(2): 87–89.
Ghersi D, Wilcken N, Simes RJ. A systematic review of taxane-containing regimens for metastatic breast cancer. British Journal of Cancer 2005; 93: 293–301.
Ghersi D, Wilcken N, Simes J, Donoghue E. Taxane containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2005; (2): CD003366.

Haran MJ, Lee BR, King MT, Marial O, Stockler MR. Health status rated with the Medical Outcomes Study 36-Item Short-Form Health Survey after spinal cord injury. Archives of Physical Medicine and Rehabilitation 2005; 86 (12): 2290–2295.

Heritier S, Gebski V, Pillai A. Dynamic balancing randomisation in controlled clinical trials. Statistics in Medicine 2005; 24: 3729–3741.
Jones M, Onslow M, Packman A, Williams S, Ormond T, Schwarz I, Gebski V. Randomised controlled trial of the Lidcombe programme of early stuttering intervention. BMJ 2005; 331(7518): 659–661.
Joshua AM, Celermajer DS, Stockler MR. Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Internal Medicine Journal 2005; 35(3): 178–187.
Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. European Heart Journal 2005; 26(2): 128–136.
Lataifeh I, Marsden DE, Robertson G, Gebski V, Hacker NF. Presenting symptoms of epithelial ovarian cancer. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005; 45 (3): 211–214.
Lee C, Giles LR, Bryden WL, Downing JL, Owens PC, Kirby AC, Wynn PC. Performance and endocrine responses of group housed weaner pigs exposed to the air quality of a commercial environment. Livestock Production Science 2005; 93: 255–262.
Lord SJ, Howard K, Allen F, Marinovich L, Burgess DC, King R, Atherton JJ. A systematic review and economic analysis of drug-eluting coronary stents available in Australia. Medical Journal of Australia 2005; 183(9): 464–471.
Lundman P, Keech AC, Griffiths K, Pillai A, Celermajer DS. New carotid plaque formation is very common in adult patients with type 2 diabetes mellitus [letter]. Diabetic Medicine 2005; 22: 355–356.
Marinovich L, Lord S, Griffiths A, and the Medical Services Advisory Committee. Positron emission tomography (PET) for epilepsy. Canberra: Department of Health and Ageing; 2004.
Medd JC, Stockler MR, Collins R, Lalak A. Measuring men's opinions of prostate needle biopsy. Australian and New Zealand Journal of Surgery 2005; 75(8): 662–664.
Nestel PJ, Baghurst K, Colquhoun DM, Simes RJ, Mehalski K, White HD, Tonkin AM, Kirby A, Pollicino C, for the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Investigators. Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial. American Journal of Clinical Nutrition 2005; 81: 1322–1329.
Newman RE, Bryden WL, Kirby AC, Storlien LH, Downing JA. Dietary n -3 and n -6 fatty acids alter avian glucose metabolism. British Poultry Science 2005; 46: 104–113.
Nowak AK, Stockler MR, Chow PKH, Findlay M. Use of tamoxifen in advanced-stage hepatocellular carcinoma: A systematic review. Cancer 2005; 103: 1408–1414.
Pavlakis N, Schmidt RL, Stockler M. Bisphosphonates for breast cancer [review]. Cochrane Database of Systematic Reviews 2005; (3): CD003474. DOI: 10.1002/14651858.CD003474.pub2.
Pollicino CA, Turner SA, Roos DE, O'Brien PC. Costing the components of pain management. Analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiotherapy and Oncology 2005; 76: 264–269.  
Qian M, Wang D, Watkins WE, Gebski V, Yan YQ, Li M, Chen ZP.The effects of iodine on intelligence in children: a meta-analysis of studies conducted in China. Asia-Pacific Journal of Clinical Nutrition 2005; 14(1): 32–42.
Shakespeare TP, Thiagarajan A, Gebski V. Evaluation of the quality of radiotherapy randomized trials for painful bone metastases. Cancer 2005; 103(9): 1976–1981.
Sinnaeve PR, Simes J, Yusuf S, Garg J, Mehta S, Eikelboom J, Bittl JA, Serruys P, Topol EJ, Granger CB. Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. European Heart Journal 2005; 26: 2396–2403.
Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation 2005;111: 1756–1762.
Stockler M. Review: Bisphosphonates are modestly better than placebo for relieving painful bone metastases. ACP Journal Club 2005; 143(1): 13.
Stockler M, on behalf of Stockler M, on behalf of Pillai A, Vardy J, Warr D. Acetaminophen in cancer pain. In reply [letter]. Journal of Clinical Oncology 2005; 23(7): 1586–1587.
Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncology 2005; 6: 581–588.
Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 2005; 112 (2): 171–178.
Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G. Effect of pravastatin in people with diabetes and chronic kidney disease. Journal of the American Society of Nephrology 2005; 16(12): 3748–3754.
Van Der Weyden MB, Ghersi D. The Australian Clinical Trial Registry [editorial]. Medical Journal of Australia 2005: 83(1): 7.
Veness MJ, Morgan GJ, Sathiyaseelan Y, Gebski V . Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg 2005; 75(3): 101–105.
Wetzig NR, Gill PG, Ung O, Collins J, Kollias J, Gillett D, Gebski V, Greig C, Ray A, Stockler M; for the RACS SNAC Group. Participation in the RACS sentinel node biopsy versus axillary clearance trial. ANZ J Surg 2005; 75(3): 98–100.
Wong CK, French JK, Aylward PE, Stewart RA, Gao W, Armstrong PW, Van De Werf FJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD; HERO-2 Trial Investigators. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. Journal of the American College of Cardiology 2005; 46(1): 29–38.
Collaborative groups
Hiukka A, Fruchart-Najib J, Leinonen E, Hilden H, Fruchart JC, Taskinen MR. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Diabetologia 2005; 48: 1207–1215. [FIELD]
Westerbacka J, Leinonen E, Salonen JT, Salonen R, Hiukka A, Yki-Järvinen, Taskinen MR. Increased augmentation of central blood pressure is associated with increases in carotid intima–media thickness in type 2 diabetic patients. Diabetologia 2005; 48: 1654–1662. [FIELD]
 
Book chapters
Berlin JA, Ghersi D. Publication bias: recognizing the problem, understanding its originas and scope, and preventing harm. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication bias in meta-analysis : prevention, assessment and adjustments. Chichester: Wiley; 2005.
Gebski VJ, Heritier S, Pillai A, Luke V, Simes RJ, Keech AC. Computer modelling of adaptive randomisation schemes in large randomised controlled trials. Sydney: Statistical solutions to modern problems: Proceedings of the 20th International Workshop on Statistical Modelling; University of Western Sydney; 2005.
Mister R, Delahunty N, Grosbard A. Recruitment and retention of research subjects. In: Fedor CA, Cola PA, Pierre C, editors. Responsible research: a guide for coordinators. London: Remedica; 2005.
 
Reports

Higgins A, Lord S, Salkeld G, and the Medical Services Advisory Committee. Endometrial ablation techniques for chronic refractory menorrhagia. Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

Lord S, Ghersi D, Simes J, Irwig L, and the Medical Services Advisory Committee. Guidelines for the assessment of diagnostic technologies. Canberra: Department of Health and Ageing; 2005.

Lord S, Rochow K, Wortley W, Ghersi D, and the Medical Services Advisory Committee. Review of current practices and future directions in the diagnosis, prevention and treatment of lymphoedema in Australia. Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

Lord S, Walder S, Howard K, and the Medical Services Advisory Committee. Magnetic resonance cholangiopancreatography. Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

Marinovich L, Lord S, Griffiths A, Eckermann S, and the Medical Services Advisory Committee. Brachytherapy for the treatment of prostate cancer. Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

Simes J, Lord S, Eckermann S, Marinovich L, Belcher J, and the Medical Services Advisory Committee. Positron emission tomography (update). Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

Walleser S, Allen F, Higgins A, Howard K, Lord S, and the Medical Services Advisory Committee. SIR-Spheres for the treatment of non-resectable liver tumours. Canberra: Department of Health and Ageing; 2005. Available at: http://www.msac.gov.au/reports.htm.

 
2004
Allen F, Marinovich L, Howard K, Lord S and the Medical Services Advisory Committee. Drug -eluting stents. Canberra: Department of Health and Ageing; 2004.
Armstrong PW, Newby LK, Granger CB, Lee KL, Simes RJ, Van de Werf F, White HD, Califf RM. Lessons learned from a clinical trial. Circulation 2004; 110(23): 3610–3614.
Atlantis E, Chow CM, Kirby A, Singh MF. An effective exercise-based intervention for improving mental health and quality of life measures: a randomized controlled trial. Preventive Medicine 2004; 39(2): 424–434.
Berlin JA, Ghersi D. Prospective meta-analysis in dentistry. Journal of Evidence-Based Dental Practice 2004; 41(1): 59–64.
Byles JE, Tavener M, O'Connell RL, Nair BR, Higginbotham NH, Jackson CL, McKernon ME, Francis L, Heller RF, Newbury JW, Marley JE, Goodger BG. Randomised controlled trial of health assessments for older Australian veterans and war widows. Medical Journal of Australia 2004; 181(4):186–190.
Byth K, Gebski V. Factorial designs: a graphical aid for choosing study designs accounting for interaction. Clinical Trials 2004; 1: 315–325.
Carrick S, Ghersi D, Simes J, Wilcken N. Platinum-containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; (2): CD003374.
Chin YS, Jayamohan J, Clouston P, Gebski V, Cakir B. Driving and patients with brain tumours: a postal survey of neurosurgeons, neurologists and radiation oncologists. Journal of Clinical Neuroscience 2004; 11(5): 471–474.
Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A, for the LIPID study investigators. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. European Heart Journal 2004; 25: 771–777.
Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Medical Journal of Australia 2004; 180: 289–291.
Eckermann SD, Kirby A. Cost-effectiveness analysis: uncertainty, predictive conditioning and extrapolation post-study: results from LIPID. In: Butler JRG, Quinn C, eds. Economics and Health 2002: Proceedings of the 24th Australian Conference of Health Economists. Sydney: Australian Health Economics Society; 2004.
Gebski V. Assessment of outcomes. Lancet Oncology 2004; 5: 761–764.
Gebski VJ. Parallel infusion of hydrocortisone ± chlorpheniramine bolus injection ot prevent acute adverse reactions to antivenom for snakebites [comment]. Medical Journal of Australia 2004; 180 (8): 429.
Ghersi D, Campbell EG, Pentz R, Cox Macpherson C. The future of institutional review boards. Lancet Oncology 2004; 5: 325–329.
Ghersi D. A prospective study of the NSW Health Shared Scientific Assessment Scheme (SSAS). In: Evaluation of the NSW Health Pilot Shared Scientific Assessment Scheme. Sydney: Health Department of NSW; 2004. ISBN 0 7347 3757 2.
Heritier S, Ronchetti E. Robust binary regression with continous outcomes. Canadian Journal of Statistics 2004; 32 (3): 239–249.
Higgins A, Lord S, Salkeld G and the Medical Services Advisory Committee. Endometrial ablation techniques for chronic refractory menorrhagia. Canberra: Department of Health and Ageing; 2004.
Hudson HM, DeGruttola V, Hargreaves C, Gebski V. Analysing variability in study effects among trials. Macquarie Statistics Research Papers 2004; (7): 1–29.
Hudson HM, Kirby A. Relative efficience of parametric and bootstrap estimates of costs. Macquarie Statistics Research Papers 2004; (26): 1–2.
Joshua AM, Stockler MR, Boyer MJ. Prolonged survival after the diagnosis of metastatic hepatic epitheliod haemangioendothelioma. Internal Medicine Journal 2004; 34(1–2): 70–71.
Kandzari DE, Granger CB, Simoons ML, White HD, Simes J, Mahaffey KW, Gore J, Weaver WD, Longstreth WT Jr, Stebbins A, Lee KL, Califf RM, Topol EJ; GUSTO-I Investigators. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-I trial). American Journal of Cardiology 2004; 93(4): 458–461.
Kassem-Moussa H, Mahaffey KW, Graffagnino C, Tasissa G, Sila CA, Simes RJ, White HD, Califf RM, Bhapkar MV, Newby LK. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. American Heart Journal 2004; 148(3): 439–446.
Keech AC, Wonders SM, Cook DI, Gebski VJ. Balancing the outcomes: reporting adverse events. Medical Journal of Australia 2004; 181(4): 215–218.
Li L, Hudson HM. Regional differences in 30-day mortality of acute myocardial infarction. Macquarie Statistics Research Papers 2004; 27: 1–17.
Liu Z, Hudson HM, Lord S, Gebski V. Decision models for valuing effectiveness of new diagnostic technologies. Macquarie Statistics Research Papers 2004; 28: 1–3.
Lord SJ, Gebski VJ, Keech AC. Multiple analyses in clinical trials: sound science or data dredging. Medical Journal of Australia 2004; 181(8): 452–454.
Lord S, Ghersi D, Gattellari M, Wortley S, Wilcken N, Simes J. Antitumour antibiotic containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; 4: CD003367.
Marinovich L, Lord S, Griffiths A, and the Medical Services Advisory Committee. Positron emission tomography (PET) for epilepsy. Canberra: Department of Health and Ageing; 2004.
Marschner IC, Emberson J, Irwig L, Walter SD. The number needed to treat (NNT) can be adjusted for bias when the outcome is measured with error. Journal of Clinical Epidemiology 2004; 57(12): 1244–1252.

Mohan PC, Tarnow-Mordi W, Stenson B, Brocklehurst P, Haque K, Cavendish V, Cust A. Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants? Archives of Disease in Childhood Fetal and Neonatal Edition 2004; 89: F5–F8.

Nowak A. Dose-dense chemotherapy as adjuvant treatment in early breast cancer. Clinical Update (National Breast Cancer Centre) 2004; 14: 1–2.
Nowak A, Chow PKH, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. European Journal of Cancer 2004; 40(10): 1474–1484.
Nowak A, Findlay M, Culjak G, Stockler M. Tamoxifen for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004; (3): CD001024
Nowak A, Stockler M, Byrne M. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. Journal of Clinical Oncology 2004; 22(15): 3172–3180.
Nowak A, Wilcken NRC, Stockler MR, Hamilton A, Ghersi D. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncology 2004; 5(6): 372–380.
O'Connell RL, Gebski VJ, Keech AC. Making sense of trial results: outcomes and estimation. Medical Journal of Australia 2004; 180: 128–130.
Seale JP, Gebski VJ, Keech AC. Generalising the results of trials to clinical practice. Medical Journal of Australia 2004; 181 (10): 558–560.
Simes RJ, Gebski VJ, Keech AC. Subgroup analysis: application to individual patient decisions. Medical Journal of Australia 2004; 180: 467–469.
Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already on a strong opioid regimen: a randomized, double-blind, placebo-controlled, cross-over trial. Journal of Clinical Oncology 2004; 22(16): 3389–3394.
Tarnow-Mordi WO, Gebski V, Cust A. Noninvasive ventilation [letter]. New England Journal of Medicine 2004; 351(12): 1257.
Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004; 110(12): 1557–1563.
Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, Beale P, Stockler M, Lonergan R, Dennien B, Waugh R, Clarke SJ. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. British Journal of Cancer 2004; 91(6): 1045–1049.
 
CTC collaborative groups
Evaluation of the NSW Health Pilot Shared Scientific Assessment Scheme. Sydney: Health Department of NSW; 2004. ISBN 0 7347 3757 2. [ V Gebski, A Keech, members of the Shared Scientific Assessment Committee; D Ghersi, member of the Shared Scientific Assessment Scheme Reference Group]
FIELD study investigators. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. ISRCTN64783481. Cardiovascular Diabetology 2004; 3: 9. [Keech AC, study chair, Forder P, Pillai A, study statisticians, Simes RJ, executive committee; NHMRC CTC, coordinating centre]
Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757–767 [Keech AC, member of Steering Committee].
Gill GP. Sentinel lymph node biopsy versus axillary clearance in operable breast cancer: the RACS SNAC trial, a multicenter randomized trial of the Royal Australian College of Surgeons (RACS) Section of Breast Surgery, in collaboration with the National Health and Medical Research Council Clinical Trials Center. Annals of Surgical Oncology 2004; 11 (3 suppl.): 216S–221S. [SNAC trial coordinating centre]
Leinonen E, Hiukka A, Hurt-Camejo E, Wiklund O, Sarna S, Mattson Hultén L, Westerbacka J, Salonen R, Salonen T, Taskinen M-R. Low-grade inflammation, endothelial activation, and carotid intima-media thickness in type 2 diabetes. Journal of Internal Medicine 2004; 256: 119–127. [FIELD study coordinating centre]
Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR. Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes. Diabetes Care 2002; 25(10): 1807–1812. [FIELD study coordinating centre]
 
2003
Augustin CB, Cakir B. The results of an Australia and New Zealand survey on the current practice of chest immobilisation during radiation therapy. The Radiographer 2003; 50: 73–77.
Babington S, Veness MJ, Cakir B, Gebski VJ, Morgan GJ. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ Journal of Surgery 2003; 73(8): 621-625.
Burgess DC, Gebski VJ, Keech AC. Baseline data in clinical trials. MJA 2003; 179(2): 105-107.
Cakir B, Gebski VJ, Keech AC. Flow of participants in randomised studies. Medical Journal of Australia 2003; 178(7):347–349.
Cust AE, Darlow BA, Donoghue DA, on behalf of the Australian and New Zealand Neonatal Network (ANZNN). Outcomes for high risk New Zealand newborn infants in 1998–1999: a population based, national study. Archives of Diseases in Childhood 2003; 88: F15–F22.
Darlow BA, Cust AE, Donoghue DA, on behalf of the Australian and New Zealand Neonatal Network (ANZNN). Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data. Archives of Diseases in Childhood 2003; 88: F23–F28.
Duric V, Butow P, Sharpe L, Lobb E, Meiser B, Barratt A, Tucker K. Reducing psychological distress in a genetic counseling consultation for breast cancer. Journal of Genetic Counseling 2003: 12: 243–264.
Eckermann SD, Martin AJ, Stockler MR, Simes RJ. The benefits and costs of tamoxifen for breast cancer prevention. Australian and New Zealand Journal of Public Health 2003; 27(1): 34-40.
Galbraith S, Marschner IC. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. Statistics in Medicine 2003; 22(11): 1787–1805.
Gebski VJ, Keech AC. Statistical methods in clinical trials. Medical Journal of Australia 2003: 178(4): 182-184.
Ghersi D, Wilcken N, Simes J, Donoghue E. Taxane containing regimens for metastatic breast cancer. Cochrane Database Systematic Reviews 2003;(3):CD003366.
Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N.A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 2003; 327(7408): 195–200.
Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. American Heart Journal 2003; 145(4): 643–651.
Hague WE, Gebski VJ, Keech AC. Recruitment to randomised studies. Medical Journal of Australia 2003; 178(11): 579—581.
Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Medical Journal of Australia 2003; 179 (8): 438–440.
Hornbuckle J, Culjak G, Jarvis E, Gebski V, Coates A, Mann G, Kefford R. Patterns of metastases in familial and non-familial melanoma. Melanoma Research 2003; 13(1): 105-109.
Jefford M, Stockler MR, Tattersall MHN. Outcomes research: what is it and why does it matter? Internal Medicine Journal 2003; 33: 110–118.
Keech AC, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A, for the LIPID study group. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes Care 2003; 26: 2713–2721.
Keech AC, Gebski VJ. Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects [letter]. Medical Journal of Australia 2003; 178(7): 357.
Kirby A, Gebski V, Keech AC. Determining the sample size in a clinical trial [letter]. Medical Journal of Australia 2003; 178(7): 358.
Kneebone A, Gebski V, Hogendoorn N, Turner S. A randomized trial evaluating rigid immobilization for pelvic irradiation. International Journal of Radiation Oncology, Biology, and Physics 2003; 56(4): 1105–1111.
Kneebone A, Turner S, Berry M, Cakir B, Gebski V. Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Australasian Radiology 2003; 47: 422–427.
Kneebone A, Turner S, Berry M, Cakir B, Gebski V. Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Australasian Radiology 2003; 47: 422–427.
Kramer JM, Newby LK, Chang W-C, Simes RJ, Van de Werf F, Granger CB, Lee KL, White HD, Piegas LS, Topol EJ, Califf RM, Armstrong PW, for the SYMPHONY and 2nd SYMPHONY Investigators. International variation in the use of evidence-based medicines for acute coronary syndromes. European Heart Journal 2003; 24: 2133–2141.
Magliano D, Liew D, Pater H, Kirby A, Hunt D, Simes J, Sundararajan V, Tonkin A. Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. Australian and New Zealand Journal of Public Health 2003; 27: 649–653.
Pike R, Keech AC, Simes RJ. Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21–23 October 2002. Medical Journal of Australia 2003; 178(7): 316–317.
Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361(9359): 777–780.
Stewart RAH, North FM, West TM, Sharples KJ, Simes RJ, Colquhoun DM, White HD, Tonkin AM, for the LIPID Study Investigators. Depression and cardiovascular mortality: cause or consequence? European Heart Journal 2003; 24: 2027–2037.
Stockler MR , Wilcken NJC, Coates AS. Chemotherapy for advanced breast cancer—how long should it continue? Breast Cancer Research and Treatment 2003; 81 (suppl. 1): S49–S52.
Tarnow-Mordi WO, Brocklehurst P, Cust A, Gates S. Clinical trials for tomorrow funded by the MRC [letter]. BMJ, 13 Aug 03. Available at http://bmj.bmjjournals.com/cgi/eletters/327/7409/240#35623 [accessed 5 Dec 03].
Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. The Laryngoscope 2003; 113: 1827; 1827–1833.
Wilcken NRC, Stockler MR. Fulvestrant: spreading the word, but not too thinly. Lancet 2003; 362 (9392): 1254.
 
CTC collaborative groups
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 4963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005–2016. [Keech AC, member of Steering Committee]
Leinonen E, Hurt-Camejo E, Wiklund O, Hulten L.M, Hiukka A, Taskinen M-R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003; 166(2): 387–394. [FIELD study coordinating centre]
PCAT Collaboration. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow-up and analysis of individual patient data from randomized trials [Patel A*, Simes RJ*, Jones M†]. American Heart Journal 2003; 145(1): 47–57 *Member of writing committee; †Study statistician.
PROGRESS Collaborative Group [Simes J*]. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes amng patients with cerebrovascular disease. European Heart Journal 2003; 24: 475–484. *Member of Data Monitoring Committee
Reports
Belcher J, Coleman K, Eckermann S, and the MSAC Supporting Committee for Laparoscopic Adjustable Gastric Banding. Laparoscopic adjustable gastric banding for morbid obesity. Canberra : Department of Health and Ageing; 2003.
Coleman K, Barr E, Wortley S, Ghersi D, and the Ostase Supporting Committee. Ostase immunoassay for the mass measurement of serum bone alkaline phosphatase. Canberra: Department of Health and Ageing; 2003.
Howard K, Stockler M and the Medical Services Advisory Committee. Selective internal radiation therapy for hepatic metastases using SIR-Spheres. Canberra: Department of Health and Ageing; 2003. ISBN 0 642 82169 0 (paper); ISSN 1443-7120 (print), ISSN 1443-7139 (online).